guanethidine has been researched along with digoxin in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (56.25) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Koch-Weser, J | 1 |
Hunter, KR; Laurence, DR; Stern, GM | 1 |
Fabre, J | 1 |
Hovland, KR | 1 |
Gulati, OD; Jaykar, S | 1 |
Emchenko, VI; Ianovskiĭ, GV; Zhadan, IN | 1 |
Namaji, KJ; Sadre, NL; Tiwari, NM | 1 |
BARTTER, FC; GILL, JR; MASON, DT | 1 |
FRANK, MJ; LASKER, N; LEVINSON, GE; PACIFICO, AD | 1 |
2 review(s) available for guanethidine and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effects of drugs on aqueous humor dynamics.
Topics: Adrenal Cortex Hormones; Anesthetics; Animals; Carbonic Anhydrase Inhibitors; Cats; Chymotrypsin; Contraceptives, Oral; Digitalis Glycosides; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Guanethidine; Humans; Hypnotics and Sedatives; Intraocular Pressure; Ouabain; Parasympatholytics; Parasympathomimetics; Pargyline; Propranolol; Rabbits; Sympathomimetics; Tranquilizing Agents; Vasodilator Agents | 1971 |
14 other study(ies) available for guanethidine and digoxin
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Drug interactions in cardiovascular therapy].
Topics: Antidepressive Agents; Biological Transport; Biotransformation; Cardiovascular Diseases; Dicumarol; Digoxin; Drug Interactions; Guanethidine; Humans; Intestinal Absorption; Kinetics; Protein Binding; Serum Albumin | 1976 |
Use of levodopa with other drugs.
Topics: Adult; Aged; Antidepressive Agents; Antiemetics; Digoxin; Dihydroxyphenylalanine; Diuretics; Drug Antagonism; Drug Synergism; Female; Guanethidine; Humans; Hypertension; Hypnotics and Sedatives; Hypoglycemic Agents; Hypotension; Male; Middle Aged; Nausea; Parkinson Disease; Pyridoxine; Time Factors | 1970 |
[Management of drug therapy in presence of renal insufficiency].
Topics: Aged; Dehydration; Digoxin; Drug-Related Side Effects and Adverse Reactions; Furosemide; Guanethidine; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Pharmaceutical Preparations; Tetracycline; Uremia | 1972 |
Effect of metabolic poisons and digoxin on the adrenergic neurone blocking action of guanethidine.
Topics: Animals; Digoxin; Dinitrophenols; Drug Antagonism; Drug Synergism; Guanethidine; Ileum; Iodoacetates; Neurons; Rabbits; Stimulation, Chemical; Sympathetic Nervous System | 1972 |
[Dynamics of the functional condition of the myocardium in Isobarin treatment of patients with hypertension].
Topics: Digoxin; Guanethidine; Heart; Humans; Hypertension; Lanatosides | 1969 |
Effect of pretreatment by digoxin, reserpine, bretylium tosylate and guanethidine on response of rat auricles to noradrenaline.
Topics: Animals; Bretylium Compounds; Digoxin; Guanethidine; Heart Atria; Norepinephrine; Rats; Reserpine | 1967 |
"IDIOPATHIC" EDEMA RESULTING FROM OCCULT CARDIOMYOPATHY.
Topics: Cardiac Catheterization; Cardiomyopathies; Desoxycorticosterone; Diagnosis; Digoxin; Drug Therapy; Edema; Guanethidine; Heart Diseases; Heart Failure; Humans | 1965 |
CARDIOVASCULAR FUNCTION IN PERITONEAL DIALYSIS.
Topics: Anemia; Blood Pressure; Blood Pressure Determination; Blood Urea Nitrogen; Blood Volume; Cardiac Catheterization; Cardiac Output; Cardiovascular System; Dialysis; Digoxin; Drug Therapy; Glomerulonephritis; Guanethidine; Humans; Methyldopa; Peritoneal Dialysis; Pyelonephritis; Renal Dialysis; Urine | 1965 |